Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

ClinicalTrials.gov ID: NCT02091986

Public ClinicalTrials.gov record NCT02091986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 4:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose is to investigate the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared with Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to \<12 Years with Asthma during 12 weeks.

Study identification

NCT ID
NCT02091986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
882 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2014
Primary completion
Mar 31, 2016
Completion
Mar 31, 2016
Last update posted
Apr 9, 2017

2014 – 2016

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
59
Facility City State ZIP Site status
Research Site Hoover Alabama
Research Site Montgomery Alabama
Research Site Gilbert Arizona
Research Site Little Rock Arkansas
Research Site Huntington Beach California
Research Site Long Beach California
Research Site Mission Viejo California
Research Site Newport Beach California
Research Site Ontario California
Research Site Stockton California
Research Site Walnut Creek California
Research Site Colorado Springs Colorado
Research Site Denver Colorado
Research Site Aventura Florida
Research Site Coral Gables Florida
Research Site Fort Walton Beach Florida
Research Site Hialeah Florida
Research Site Homestead Florida
Research Site Jacksonville Florida
Research Site Largo Florida
Research Site Miami Florida
Research Site Williston Florida
Research Site Winter Park Florida
Research Site Savannah Georgia
Research Site Stockbridge Georgia
Research Site Lenexa Kansas
Research Site Waldorf Maryland
Research Site Plymouth Minnesota
Research Site Bellevue Nebraska
Research Site Verona New Jersey
Research Site Albuquerque New Mexico
Research Site Rockville Centre New York
Research Site Watertown New York
Research Site Charlotte North Carolina
Research Site Canton Ohio
Research Site Cincinnati Ohio
Research Site Toledo Ohio
Research Site Edmond Oklahoma
Research Site Oklahoma City Oklahoma
Research Site Gresham Oregon
Research Site Medford Oregon
Research Site Portland Oregon
Research Site Upland Pennsylvania
Research Site North Charleston South Carolina
Research Site Spartanburg South Carolina
Research Site West Columbia South Carolina
Research Site Allen Texas
Research Site Baytown Texas
Research Site El Paso Texas
Research Site Fort Worth Texas
Research Site Houston Texas
Research Site Kerville Texas
Research Site Richmond Texas
Research Site San Antonio Texas
Research Site Waco Texas
Research Site Murray Utah
Research Site Fairfax Virginia
Research Site Tacoma Washington
Research Site Washington Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02091986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2017 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02091986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →